Table 1.
The association of IL-17C levels at pre-conditioning with clinical factors.
| Factors | Total | IL-17c ≥ 106.32 | IL-17c < 106.32 | P value |
|---|---|---|---|---|
| Age median | 28 (3–59) | 27.5 (3–59) | 29 (13–52) | 0.904 |
| GENDER | ||||
| Male | 41 | 25 | 16 | 0.428 |
| Female | 27 | 19 | 8 | |
| Donor age | 36 (16–55) | 37 (16–52) | 35 (18–55) | 0.887 |
| PATIENT-DONOR | ||||
| Match | 44 | 30 | 14 | 0.417 |
| Mismatch | 24 | 14 | 10 | |
| GVHD | ||||
| CsA based | 48 | 32 | 16 | 0.189 |
| Fk506 based | 20 | 12 | 8 | |
| DONOR TYPE | ||||
| Related | 48 | 32 | 16 | 0.600 |
| Unrelated | 20 | 12 | 8 | |
| DIAGNOSIS | ||||
| AML | 29 | 20 | 9 | 0.263 |
| ALL | 23 | 14 | 9 | |
| MDS | 6 | 2 | 4 | |
| CML | 10 | 8 | 2 | |
| DISEASE STATUS | ||||
| Standard risk | 48 | 32 | 16 | 0.600 |
| High risk | 20 | 12 | 8 | |
| aGVHD GRADE | ||||
| 0 | 14 | 11 | 3 | 0.005 |
| I | 26 | 20 | 6 | |
| II | 19 | 11 | 8 | |
| III | 5 | 1 | 4 | |
| IV | 4 | 1 | 3 | |
| PROGNOSIS | ||||
| Survival | 49 | 35 | 14 | 0.173 |
| Replase | 8 | 4 | 4 | |
| Other | 11 | 5 | 6 | |